文献速递精神分裂症与精神病性障碍会诊联络精神医学

与母亲精神分裂症谱系障碍及产前抗精神病药使用相关的不良产科和新生儿结局:37,214,330次妊娠分娩的Meta分析及评估风险估计混杂依赖性的倾向评分加权人群队列研究

Adverse obstetric and neonatal outcomes associated with maternal schizophrenia-spectrum disorders and prenatal antipsychotic use: a meta-analysis of 37,214,330 pregnancy deliveries and propensity-score weighted population-based cohort study assessing confounder dependency of risk estimates.
PubMed 文献 · Mol Psychiatry · 2024-09-02

Meta分析纳入18项研究、37,214,330名女性(含42,926名精神分裂症谱系障碍女性),发现该障碍与17项不良产科/新生儿结局中的12项显著相关(汇总相对风险1.12-2.10)。香港人群队列(466,358名女性,含804名患者)经倾向评分加权调整后,多数风险显著衰减或不再显著,仅引产住院≥7天、早产和新生儿特殊护理入院仍显著;接受治疗与未治疗患者间除新生儿特殊护理入院外无显著差异。

要点

  • Meta分析显示精神分裂症谱系障碍与12/17项不良产科/新生儿结局显著相关,汇总相对风险1.12-2.10。
  • 倾向评分加权队列中多数关联衰减或不再显著,仅引产住院≥7天、早产和新生儿特殊护理入院仍显著。
  • 接受治疗与未治疗患者间除新生儿特殊护理入院外无显著差异。

核心结论

  • 精神分裂症谱系障碍女性中报告的大多数产科/新生儿并发症风险升高,可能很大程度上可由母亲躯体共病、物质/酒精使用障碍及其他混杂因素解释。
  • 作者建议将针对可改变的母亲危险因素的干预纳入精神分裂症谱系障碍女性的产前保健,以尽量减少可避免的不良结局。

研究设计与样本

  • Meta分析检索四个数据库自建库至2023年10月31日,采用随机效应模型生成汇总风险估计。
  • 人群队列研究从香港公共医疗电子健康记录数据库识别2003年至2018年间分娩首次/单胎的15-50岁精神分裂症谱系障碍女性。
  • 采用倾向评分加权回归分析纳入重要混杂因素(母亲既往和妊娠期疾病、物质/酒精滥用及精神药物使用),比较患者与非患者及治疗与未治疗亚组。

主要发现

  • Meta分析(18项研究,37,214,330名女性,含42,926名患者)发现精神分裂症谱系障碍与17项分析的不良产科/新生儿结局中的12项显著相关,汇总相对风险范围为1.12-2.10。
  • 上述12项包括胎盘并发症、引产、剖宫产、胎儿窘迫、死产、早产、小于胎龄儿、低出生体重、低APGAR评分、新生儿和新生儿后期死亡。
  • 队列研究(466,358名女性,含804名患者)中,未调整模型多数结局风险升高,倾向评分加权调整后显著衰减或不再显著。
  • 仅引产住院≥7天(OR=1.76,95%CI=1.33-2.34)、早产(OR=1.48,95%CI=1.09-2.00)和新生儿特殊护理入院(OR=1.65,95%CI=1.35-2.01)仍显著。
  • 接受治疗患者较未治疗患者新生儿特殊护理入院更高(OR=1.75,95%CI=1.23-2.52),其他结局两组间无显著差异。

关键数值与推荐

  • Meta分析汇总相对风险范围为1.12-2.10,对应精神分裂症谱系障碍与12项不良产科/新生儿结局的显著关联。
  • 倾向评分加权调整后,引产住院≥7天OR=1.76(95%CI=1.33-2.34),早产OR=1.48(95%CI=1.09-2.00),新生儿特殊护理入院OR=1.65(95%CI=1.35-2.01)。
  • 接受治疗与未治疗患者比较,新生儿特殊护理入院OR=1.75(95%CI=1.23-2.52),其他结局无显著组间差异。

临床怎么用

  • 作者建议将针对可改变的母亲危险因素的干预纳入精神分裂症谱系障碍女性的产前保健,以尽量减少可避免的不良结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Studies demonstrated increased obstetric and neonatal complications in women with schizophrenia-spectrum disorder (SSD), but most inadequately addressed confounders and rarely considered antipsychotic effects. We conducted a meta-analysis and a population-based cohort study evaluating associations of adverse obstetric/neonatal outcomes with SSD and prenatal antipsychotic use. In the meta-analysis, we searched four databases from inception to October-31-2023 and generated pooled risk estimates using random-effect models. In the cohort study, we identified women aged 15-50 years with SSD-diagnosis from electronic-heath-record database of public healthcare-services who delivered first/singleton children between 2003 and 2018 in Hong Kong. Propensity-score weighted regression-analyses incorporating important confounders including maternal pre-existing and gestational morbidities, substance/alcohol abuse, and psychotropic use, were performed to assess risk of adverse obstetric/neonatal outcomes in SSD-women versus non-SSD-women, and subsequently treated-SSD and untreated-SSD subgroups to disentangle effects of SSD from antipsychotic exposure. The meta-analysis (studies = 18, women = 37,214,330, including 42,926 SSD-women) found significant associations of SSD with 12 of 17 analyzed negative obstetric/neonatal outcomes (with pooled relative risk ranged:1.12-2.10), including placental complications, induced labor, Caesarean delivery, fetal distress, stillbirth, preterm birth, small-for-gestational-age, low birth weight, low APGAR scores, neonatal and post-neonatal deaths. However, the cohort study (466,358 women, including 804 SSD-women) revealed that elevated risk of most study outcomes in unadjusted-models were markedly-attenuated or became non-significant in propensity-score weighted adjusted-models, except index-delivery hospitalization ≥7 days (odds ratio [OR] = 1.76 [95% CI = 1.33-2.34]), preterm birth (OR = 1.48 [95% CI = 1.09-2.00]) and neonatal special-care admission (OR = 1.65 [95% CI = 1.35-2.01]). Apart from higher neonatal special-care admission in treated-SSD than untreated-SSD women (OR = 1.75 [95% CI = 1.23-2.52]), no significant between-group differences emerged in other outcomes. In sum, elevated risk of most obstetric/neonatal complications reported in SSD-women might largely be explained by maternal physical comorbidities, substance/alcohol use disorders and other confounders. Interventions targeting modifiable maternal risk factors should be incorporated in prenatal care for SSD-women to minimize avoidable adverse outcomes.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chan JKN, Lee KCK, Correll CU, et al. Adverse obstetric and neonatal outcomes associated with maternal schizophrenia-spectrum disorders and prenatal antipsychotic use: a meta-analysis of 37,214,330 pregnancy deliveries and propensity-score weighted population-based cohort study assessing confounder dependency of risk estimates. Mol Psychiatry. 2024. PMID: 39223277. doi:10.1038/s41380-024-02723-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。